ProKidney
The development of a cell therapy candidate that has the potential to improve the lives of patients with chronic kidney disease. Learn more
Launch date
Employees
Market cap
€273m
Enterprise valuation
(€114m) (Public information from Sep 2024)
Share price
$2.39 PROK
Winston-Salem North Carolina (HQ & founding location)
Authorizing premium user...